Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

Clinical trial NCT07428499 · RECRUITING

Trial details

NCT number: NCT07428499
Sponsor: ADARx Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema (HAE)Hereditary Angioedema - Type 1 Hereditary Angioedema - Type 2 HAE

Start date: 2026-04-02
Primary completion: 2030-06-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.